These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 33320846)

  • 1. A mechanistic framework for a priori pharmacokinetic predictions of orally inhaled drugs.
    Hartung N; Borghardt JM
    PLoS Comput Biol; 2020 Dec; 16(12):e1008466. PubMed ID: 33320846
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predicting Exposure After Oral Inhalation of the Selective Glucocorticoid Receptor Modulator, AZD5423, Based on Dose, Deposition Pattern, and Mechanistic Modeling of Pulmonary Disposition.
    Bäckman P; Tehler U; Olsson B
    J Aerosol Med Pulm Drug Deliv; 2017 Apr; 30(2):108-117. PubMed ID: 27740878
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predicting Pulmonary Pharmacokinetics from In Vitro Properties of Dry Powder Inhalers.
    Bhagwat S; Schilling U; Chen MJ; Wei X; Delvadia R; Absar M; Saluja B; Hochhaus G
    Pharm Res; 2017 Dec; 34(12):2541-2556. PubMed ID: 28799097
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of epimeric budesonide and fluticasone propionate after repeat dose inhalation--intersubject variability in systemic absorption from the lung.
    Minto C; Li B; Tattam B; Brown K; Seale JP; Donnelly R
    Br J Clin Pharmacol; 2000 Aug; 50(2):116-24. PubMed ID: 10930963
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pulmonary Dissolution of Poorly Soluble Compounds Studied in an ex Vivo Rat Lung Model.
    Eriksson J; Thörn H; Sjögren E; Holmstén L; Rubin K; Lennernäs H
    Mol Pharm; 2019 Jul; 16(7):3053-3064. PubMed ID: 31136181
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetic profile analyses for inhaled drugs in humans using the lung delivery and disposition model.
    Raut A; Dhapare S; Venitz J; Sakagami M
    Biopharm Drug Dispos; 2020 Feb; 41(1-2):32-43. PubMed ID: 31691979
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systems Pharmacology Approach for Prediction of Pulmonary and Systemic Pharmacokinetics and Receptor Occupancy of Inhaled Drugs.
    Boger E; Evans N; Chappell M; Lundqvist A; Ewing P; Wigenborg A; Fridén M
    CPT Pharmacometrics Syst Pharmacol; 2016 Apr; 5(4):201-10. PubMed ID: 27104089
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of particle deposition density of dry powders on the results produced by an in vitro test system simulating dissolution- and absorption rates in the lungs.
    Malmlöf M; Nowenwik M; Meelich K; Rådberg I; Selg E; Burns J; Mascher H; Gerde P
    Eur J Pharm Biopharm; 2019 Jun; 139():213-223. PubMed ID: 30862480
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Systematic Analysis of the Sensitivity of Plasma Pharmacokinetics to Detect Differences in the Pulmonary Performance of Inhaled Fluticasone Propionate Products Using a Model-Based Simulation Approach.
    Weber B; Hochhaus G
    AAPS J; 2015 Jul; 17(4):999-1010. PubMed ID: 25933600
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Single-dose and steady-state pharmacokinetic and pharmacodynamic evaluation of therapeutically clinically equivalent doses of inhaled fluticasone propionate and budesonide, given as Diskus or Turbohaler dry-powder inhalers to healthy subjects.
    Möllmann H; Wagner M; Krishnaswami S; Dimova H; Tang Y; Falcoz C; Daley-Yates PT; Krieg M; Stöckmann R; Barth J; Lawlor C; Möllmann AC; Derendorf H; Hochhaus G
    J Clin Pharmacol; 2001 Dec; 41(12):1329-38. PubMed ID: 11762560
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systemic bioavailability and potency of high-dose inhaled corticosteroids: a comparison of four inhaler devices and three drugs in healthy adult volunteers.
    Wales D; Makker H; Kane J; McDowell P; O'Driscoll BR
    Chest; 1999 May; 115(5):1278-84. PubMed ID: 10334140
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of PBPK Modeling To Evaluate the Performance of Dissolv It, a Biorelevant Dissolution Assay for Orally Inhaled Drug Products.
    Hassoun M; Malmlöf M; Scheibelhofer O; Kumar A; Bansal S; Selg E; Nowenwik M; Gerde P; Radivojev S; Paudel A; Arora S; Forbes B
    Mol Pharm; 2019 Mar; 16(3):1245-1254. PubMed ID: 30640475
    [TBL] [Abstract][Full Text] [Related]  

  • 13. On the pharmacokinetics of two inhaled budesonide/formoterol combinations in asthma patients using modeling approaches.
    Soulele K; Macheras P; Karalis V
    Pulm Pharmacol Ther; 2018 Feb; 48():168-178. PubMed ID: 29223508
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative physicochemical and pharmacokinetic profiles of inhaled beclomethasone dipropionate and budesonide.
    Boobis AR
    Respir Med; 1998 Jul; 92 Suppl B():2-6. PubMed ID: 10193529
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of the Transwell System for Characterization of Dissolution Behavior of Inhalation Drugs: Effects of Membrane and Surfactant.
    Rohrschneider M; Bhagwat S; Krampe R; Michler V; Breitkreutz J; Hochhaus G
    Mol Pharm; 2015 Aug; 12(8):2618-24. PubMed ID: 26091361
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhaled Therapy in Respiratory Disease: The Complex Interplay of Pulmonary Kinetic Processes.
    Borghardt JM; Kloft C; Sharma A
    Can Respir J; 2018; 2018():2732017. PubMed ID: 30018677
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics and pharmacodynamics of inhaled corticosteroids.
    Derendorf H; Hochhaus G; Meibohm B; Möllmann H; Barth J
    J Allergy Clin Immunol; 1998 Apr; 101(4 Pt 2):S440-6. PubMed ID: 9563369
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ciclesonide and budesonide suspensions for nebulization delivery: An in vivo inhalation biopharmaceutics investigation.
    Fu TT; Zhao Y; Yang FF; Wen H; Liu CY; Liao YH
    Int J Pharm; 2018 Oct; 549(1-2):21-30. PubMed ID: 30048776
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacometric Models for Characterizing the Pharmacokinetics of Orally Inhaled Drugs.
    Borghardt JM; Weber B; Staab A; Kloft C
    AAPS J; 2015 Jul; 17(4):853-70. PubMed ID: 25845315
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics and systemic activity of fluticasone via Diskus and pMDI, and of budesonide via Turbuhaler.
    Thorsson L; Edsbäcker S; Källén A; Löfdahl CG
    Br J Clin Pharmacol; 2001 Nov; 52(5):529-38. PubMed ID: 11736861
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.